23.50USD0.00%Mkt Cap: 151.86M $P/E: —18d ago
Assertio Holdings, Inc., a pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate t…
Industry Peers
Drug Manufacturers - Specialty & Generic$65.19BUSDP/E 23.7
$22.46BUSDP/E 19.5
$20.18BUSD
$17.25BUSDP/E 26.4
$15.47BUSDP/E 179.2
$14.18BUSDP/E 29.7
$12.96BUSD
$8.93BUSDP/E 22.7
$7.80BUSD
$6.84BUSDP/E 25.1
$6.69BUSDP/E 442.8
$5.76BUSDP/E 48.8
$3.65BUSDP/E 19.0
$3.55BUSDP/E 11.3
$2.99BUSDP/E 20.9
$2.80BUSD
$2.52BUSDP/E 56.0
$2.35BUSDP/E 16.3
$2.40BUSDP/E 12.9
$2.31BUSD
$1.92BUSDP/E 19.4
$1.89BUSD
$1.86BUSDP/E 21.0
$1.71BUSD
$1.89BUSD
$1.67BUSD
$1.48BUSDP/E 17.5
$1.50BUSDP/E 124.1
$1.40BUSDP/E 14.8
$1.12BUSDP/E 35.4
$1.18BUSDP/E 17.6
$1.23BUSD
$1.06BUSDP/E Infinity
$1.02BUSD
$1.01BUSDP/E 196.9
$985.07MUSD
$918.60MUSDP/E 14.7
$873.22MUSDP/E 38.1
$875.69MUSDP/E 12.0
$819.46MUSDP/E Infinity
$668.29MUSD
$692.84MUSDP/E 161.5
$637.05MUSDP/E 6.2
$505.77MUSDP/E 14.3
$494.34MUSD
$447.41MUSD
$427.80MUSD
$396.78MUSD
$375.56MUSD
$370.76MUSD
$355.90MUSD
$343.56MUSD
$357.30MUSD
$320.48MUSDP/E 43.7
$294.94MUSDP/E 15.2
$303.08MUSDP/E 9.7
$273.62MUSDP/E 49.1
$285.23MUSD
$250.29MUSDP/E 47.6
$255.34MUSDP/E 12.7
$236.39MUSDP/E 53.0
$206.95MUSDP/E 10.3
$210.49MUSD
$195.77MUSD
$185.67MUSD
$182.70MUSDP/E 8.8
$164.20MUSD
$143.26MUSDP/E 18.3
$146.07MUSD
$133.59MUSD
$126.10MUSD
$119.66MUSDP/E 18.6
$114.77MUSD
$83.73MUSDP/E 12.0
$94.75MUSD
$72.66MUSD
$67.25MUSD
$70.06MUSD
$62.42MUSDP/E 52.6
$63.44MUSDP/E 21.8
$60.48MUSD
$63.41MUSD
$53.86MUSD
$50.62MUSD
$49.37MUSD
$48.31MUSD
$42.20MUSD
$41.16MUSD
$33.86MUSDP/E Infinity
$31.75MUSD
$27.85MUSD
$26.87MUSD
$23.61MUSDP/E 204.0
$23.18MUSD
$22.62MUSD
$22.15MUSD
$18.56MUSD
$17.65MUSD
$14.93MUSD
$13.84MUSDP/E 16.8
$14.21MUSD
$11.64MUSD
$11.91MUSD
$9.88MUSD
$8.99MUSD
$8.21MUSD
$8.13MUSD
$6.05MUSDP/E 3.7
$6.17MUSD
$6.48MUSDP/E 0.3
$5.84MUSD
$5.46MUSDP/E Infinity
$3.29MUSDP/E 1.6
$2.01MUSD
$1.93MUSD
$2.08MUSDP/E 35.5
$1.54MUSD
$668.8KUSD
$173.7KUSDP/E 0.0
$175USD
Indicators:|
Key Statistics
Company
Market Cap151.86M $
Enterprise Value120.61M $
Revenue (TTM)102.16M $
Gross Profit71.85M $
Net Income (TTM)-35.69M $
Revenue/Share15.92 USD
Last Price23.50 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees53
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINLU1953136287
Valuation
P/E (Trailing)—
P/E (Forward)9.11
PEG0.89
EV/EBITDA31.51
EV/Revenue1.18
P/S1.49
P/B2.00
EPS (TTM)-5.55
EPS (Forward)2.58
52W Range
8.610100% of range23.50
52W High23.50 USD
52W Low8.610 USD
Profitability
Gross Margin70.33%
Oper. Margin-185.95%
EBITDA Margin3.75%
Profit Margin-34.94%
ROE-38.76%
ROA-5.71%
Growth
Revenue Growth-62.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.08M $
CapEx (TTM)—
FCF Margin7.59%
FCF Yield5.10%
Net Debt-31.26M $
Net Debt/EBITDA-8.17
Balance Sheet
Debt/Equity53.30
Current Ratio1.82
Quick Ratio1.45
Book Value/Sh11.73 USD
Cash/Share11.07 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateDec 26, 2025
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)24.43 USD
Upside (mean)+4.0%
Target Range21.80 USD – 28.00 USD
$21.80+4.0% to mean$28.00
# Analysts3
Ownership
Shares Out.6.46M
Float6.26M
Insiders1.97%
Institutions29.29%
Short Interest
Short Ratio0.7d
Short % Float5.25%
Short % Out.5.18%
Shares Short334.92K
Short (prev mo.)289.28K
Technical
SMA 5021.99 (+6.8%)
SMA 20014.90 (+57.7%)
Beta0.53
S&P 52W Chg20.85%
Avg Vol (30d)281.36K
Avg Vol (10d)117.67K
Technical Indicators
RSI (14)84.3
MACD0.4226
MACD Signal0.5730
MACD Hist.-0.1504
BB Upper23.53 USD
BB Middle23.47 USD
BB Lower23.40 USD
BB Width0.54%
ATR (14)0.0885 USD
Vol Ratio (20d)0.00x